TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T51076	NT-3 growth factor receptor	B1A9DU	N-(1H-Imidazol-2-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137659623	C18H16N4OS	336.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=NC=CN3)C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B3WJ9F	N-(Pyrimidin-2-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137659402	C19H16N4OS	348.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=NC=CC=N3)C4=CC=CS4	IC50 = 58440 nM	Poor binder
T51076	NT-3 growth factor receptor	B51FNC	2-(2-Pyridin-3-ylindol-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137652057	C21H18N4O	342.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=CN=CC=C4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B5JDG2	N-[(1-Methylimidazol-2-yl)methyl]-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137638843	C19H18N4OS	350.4	CN1C=CN=C1CNC(=O)CN2C3=CC=CC=C3C=C2C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B67IKH	N-(1H-Benzimidazol-2-ylmethyl)-2-[5-fluoro-2-(1,3-oxazol-2-yl)indol-1-yl]acetamide	Investigative	137657779	C21H16FN5O2	389.4	C1=CC=C2C(=C1)NC(=N2)CNC(=O)CN3C4=C(C=C(C=C4)F)C=C3C5=NC=CO5	IC50 = 68750 nM	Poor binder
T51076	NT-3 growth factor receptor	B68DHG	N-(Pyridin-4-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137642417	C20H17N3OS	347.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=NC=C3)C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B6K0AZ	2-(2-Phenylpyrrolo[3,2-b]pyridin-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137656463	C21H18N4O	342.4	C1=CC=C(C=C1)C2=CC3=C(N2CC(=O)NCC4=CC=CC=N4)C=CC=N3	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B78VZH	N-(2-Pyridin-2-ylethyl)-2-thiophen-2-ylindole-1-carboxamide	Investigative	137641283	C20H17N3OS	347.4	C1=CC=C2C(=C1)C=C(N2C(=O)NCCC3=CC=CC=N3)C4=CC=CS4	IC50 = 80270 nM	Poor binder
T51076	NT-3 growth factor receptor	B8ACN9	2-(2-Pyridin-2-ylindol-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137652242	C21H18N4O	342.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=CC=CC=N4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B97SQF	N-(1H-Benzimidazol-2-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	121272745	C22H18N4OS	386.5	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=NC4=CC=CC=C4N3)C5=CC=CS5	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B9K7ND	N-[(2-Phenyl-1H-imidazol-5-yl)methyl]-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137649400	C24H20N4OS	412.5	C1=CC=C(C=C1)C2=NC=C(N2)CNC(=O)CN3C4=CC=CC=C4C=C3C5=CC=CS5	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B9LH7N	N-(1,3-Thiazol-2-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137661074	C18H15N3OS2	353.5	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=NC=CS3)C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B9PGB1	N-(Pyridin-3-ylmethyl)-2-(2-thien-2-yl-1H-indol-1-yl)acetamide	Investigative	20907256	C20H17N3OS	347.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CN=CC=C3)C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	B9QD5X	N-[2-(2-Thiophen-2-ylindol-1-yl)ethyl]pyridine-2-carboxamide	Investigative	137644894	C20H17N3OS	347.4	C1=CC=C2C(=C1)C=C(N2CCNC(=O)C3=CC=CC=N3)C4=CC=CS4	IC50 = 80020 nM	Poor binder
T51076	NT-3 growth factor receptor	BA4FR1	2-(6-Fluoro-2-phenylindol-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137650528	C22H18FN3O	359.4	C1=CC=C(C=C1)C2=CC3=C(N2CC(=O)NCC4=CC=CC=N4)C=C(C=C3)F	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BB65DH	N-(Pyridin-2-ylmethyl)-2-thiophen-2-ylindole-1-carboxamide	Investigative	137647123	C19H15N3OS	333.4	C1=CC=C2C(=C1)C=C(N2C(=O)NCC3=CC=CC=N3)C4=CC=CS4	IC50 = 81160 nM	Poor binder
T51076	NT-3 growth factor receptor	BDFK41	2-[2-(5-Methylfuran-2-yl)indol-1-yl]-N-(pyridin-2-ylmethyl)acetamide	Investigative	137658125	C21H19N3O2	345.4	CC1=CC=C(O1)C2=CC3=CC=CC=C3N2CC(=O)NCC4=CC=CC=N4	IC50 = 73070 nM	Poor binder
T51076	NT-3 growth factor receptor	BF9EA4	2-(2-Phenylpyrrolo[2,3-c]pyridin-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137633567	C21H18N4O	342.4	C1=CC=C(C=C1)C2=CC3=C(N2CC(=O)NCC4=CC=CC=N4)C=NC=C3	IC50 = 51000 nM	Poor binder
T51076	NT-3 growth factor receptor	BFC3I8	N-Methyl-N-(pyridin-2-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137658859	C21H19N3OS	361.5	CN(CC1=CC=CC=N1)C(=O)CN2C3=CC=CC=C3C=C2C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BG5ZN2	N-(Pyridin-2-ylmethyl)-2-[2-(1,2-thiazol-3-yl)indol-1-yl]acetamide	Investigative	137659789	C19H16N4OS	348.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=NSC=C4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BKF8U2	2-(2-Phenylpyrrolo[3,2-c]pyridin-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137655170	C21H18N4O	342.4	C1=CC=C(C=C1)C2=CC3=C(N2CC(=O)NCC4=CC=CC=N4)C=CN=C3	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BLSI07	N-(1H-Benzimidazol-2-ylmethyl)-2-[2-(1,3-oxazol-2-yl)indol-1-yl]acetamide	Investigative	121272655	C21H17N5O2	371.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=NC4=CC=CC=C4N3)C5=NC=CO5	IC50 = 68160 nM	Poor binder
T51076	NT-3 growth factor receptor	BM08KT	N-(1H-Imidazol-5-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137632400	C18H16N4OS	336.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CN=CN3)C4=CC=CS4	IC50 = 120000 nM	Poor binder
T51076	NT-3 growth factor receptor	BM6VF7	N-[(5-Phenyl-1H-imidazol-2-yl)methyl]-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137653271	C24H20N4OS	412.5	C1=CC=C(C=C1)C2=CN=C(N2)CNC(=O)CN3C4=CC=CC=C4C=C3C5=CC=CS5	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BM9N7I	N-(Pyridin-2-ylmethyl)-2-[2-(1,3-thiazol-2-yl)indol-1-yl]acetamide	Investigative	137638576	C19H16N4OS	348.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=NC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BN0GM1	2-[2-(1,3-Oxazol-2-yl)indol-1-yl]-N-(pyridin-2-ylmethyl)acetamide	Investigative	137660998	C19H16N4O2	332.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=NC=CO4	IC50 = 53490 nM	Poor binder
T51076	NT-3 growth factor receptor	BQ40TL	N-(Pyridin-2-ylmethyl)-2-[2-(1,3-thiazol-5-yl)indol-1-yl]acetamide	Investigative	137640958	C19H16N4OS	348.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=CN=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BS4EC8	2-(4-Fluoro-2-phenylindol-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137634804	C22H18FN3O	359.4	C1=CC=C(C=C1)C2=CC3=C(N2CC(=O)NCC4=CC=CC=N4)C=CC=C3F	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BS9Q0L	N-[2-(2-Thiophen-2-ylindol-1-yl)ethyl]pyridine-2-sulfonamide	Investigative	137633612	C19H17N3O2S2	383.5	C1=CC=C2C(=C1)C=C(N2CCNS(=O)(=O)C3=CC=CC=N3)C4=CC=CS4	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BU0NC8	N-(Imidazo[1,2-a]pyridin-2-ylmethyl)-2-(2-thiophen-2-ylindol-1-yl)acetamide	Investigative	137657302	C22H18N4OS	386.5	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CN4C=CC=CC4=N3)C5=CC=CS5	IC50 = 71720 nM	Poor binder
T51076	NT-3 growth factor receptor	BX1P0L	2-(5-Fluoro-2-phenylindol-1-yl)-N-(pyridin-2-ylmethyl)acetamide	Investigative	137655709	C22H18FN3O	359.4	C1=CC=C(C=C1)C2=CC3=C(N2CC(=O)NCC4=CC=CC=N4)C=CC(=C3)F	IC50 ~ 81010 nM	Poor binder
T51076	NT-3 growth factor receptor	BXI4F2	N-(Pyridin-2-ylmethyl)-2-[2-(1,2-thiazol-5-yl)indol-1-yl]acetamide	Investigative	137655675	C19H16N4OS	348.4	C1=CC=C2C(=C1)C=C(N2CC(=O)NCC3=CC=CC=N3)C4=CC=NS4	IC50 = 70240 nM	Poor binder